Study type

Study topic

Disease /health condition

Study type

Non-interventional study

Scope of the study

Disease epidemiology

Data collection methods

Combined primary data collection and secondary use of data
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Longitudinal prospective epidemiological study
Study drug and medical condition

Medical condition to be studied

Immune thrombocytopenia
Population studied

Short description of the study population

All patients over 16 years old previously diagnosed (prior to inclusion visit) or newly diagnosed (at the time of the inclusion visit) with AITP, treated in the hematology departments in Algeria and who gave their informed consent, were included in the study.

Age groups

Adolescents (12 to < 18 years)
Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Immune thrombocytopenic purpura patients

Estimated number of subjects

200
Study design details

Main study objective

To assess the incidence of AITP diagnosed in patients aged 16 years old and over in Algeria in a 12-month period of inclusion

Outcomes

Number of new cases diagnosed with AITP and aged 16 years and over, in Algeria during the period of 12 months of inclusion. Number of new cases diagnosed with AITP and aged 16 years and over, during the period of 12 months of inclusion, by age categories. Number diagnosed with AITP and aged 16 years and over, in Algeria during the period of 12 months of inclusion, by gender, diagnosis stage, Wilaya.

Data analysis plan

This study is an estimation study, so no formal statistical testing will be performed. A descriptive analysis of the collected variables will be conducted.
Documents
Study results

20160214_AITP_CSR_24JULY2019_Final (002)_Redacted

English (261.64 KB - PDF)View document